<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(10)</volume><submitter>Kobo O</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Early reports described decreased admissions for acute cardiovascular events during the SarsCoV-2 pandemic. We aimed to explore whether the lockdown enforced during the SARSCoV-2 pandemic in Israel impacted the characteristics of presentation, reperfusion times, and early outcomes of ST-elevation myocardial infarction (STEMI) patients.&lt;h4>Methods&lt;/h4>A multicenter prospective cohort comprising all STEMI patients treated by primary percutaneous coronary intervention admitted to four high-volume cardiac centers in Israel during lockdown (20/3/2020-30/4/2020). STEMI patients treated during the same period in 2019 served as controls.&lt;h4>Results&lt;/h4>The study comprised 243 patients, 107 during the lockdown period of 2020 and 136 during the same period in 2019, with no diffe</pubmed_abstract><journal>PloS one</journal><pagination>e0241149</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7584161</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction.</pubmed_title><pmcid>PMC7584161</pmcid><pubmed_authors>Kofman N</pubmed_authors><pubmed_authors>Aronson D</pubmed_authors><pubmed_authors>Kobo O</pubmed_authors><pubmed_authors>Minha S</pubmed_authors><pubmed_authors>Roguin A</pubmed_authors><pubmed_authors>Efraim R</pubmed_authors><pubmed_authors>Abu Dogosh A</pubmed_authors><pubmed_authors>Saada M</pubmed_authors><pubmed_authors>Meisel SR</pubmed_authors><pubmed_authors>Abramowitz Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction.</name><description>&lt;h4>Introduction&lt;/h4>Early reports described decreased admissions for acute cardiovascular events during the SarsCoV-2 pandemic. We aimed to explore whether the lockdown enforced during the SARSCoV-2 pandemic in Israel impacted the characteristics of presentation, reperfusion times, and early outcomes of ST-elevation myocardial infarction (STEMI) patients.&lt;h4>Methods&lt;/h4>A multicenter prospective cohort comprising all STEMI patients treated by primary percutaneous coronary intervention admitted to four high-volume cardiac centers in Israel during lockdown (20/3/2020-30/4/2020). STEMI patients treated during the same period in 2019 served as controls.&lt;h4>Results&lt;/h4>The study comprised 243 patients, 107 during the lockdown period of 2020 and 136 during the same period in 2019, with no diffe</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-18T14:41:14.664Z</modification><creation>2020-10-31T09:57:40Z</creation></dates><accession>S-EPMC7584161</accession><cross_references><pubmed>33095801</pubmed><doi>10.1371/journal.pone.0241149</doi></cross_references></HashMap>